Changeflow GovPing Healthcare & Life Sciences Novel Bridged Bicycloalkyl-Substituted Aminothi...
Routine Rule Added Final

Novel Bridged Bicycloalkyl-Substituted Aminothiazoles and Their Methods of Use

Favicon for changeflow.com EPO Patent Bulletin - Organic Chemistry (C07D)
Published
Detected
Email

Summary

Temple University of the Commonwealth System of Higher Education has been granted European Patent EP4219486A1 for novel bridged bicycloalkyl-substituted aminothiazole compounds and their methods of use, published April 15, 2026. The patent designates 31 European Patent Convention member states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands. Inventors include CHILDERS Wayne E., ABOU-GHARBIA Magid A., MORTON George C., ISSA Jean-Pierre J., and ZHANG Hanghang, with applications classified under A61K 31/426 (antineoplastic pharmaceutical preparations).

“NOVEL BRIDGED BICYCLOALKYL-SUBSTITUTED AMINOTHIZOLES AND THEIR METHODS OF USE”

EPO , verbatim from source
Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Organic Chemistry (C07D) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.

What changed

European Patent EP4219486A1 has been granted to Temple University for novel bridged bicycloalkyl-substituted aminothiazole compounds and methods of use, with designation across 31 European Patent Convention member states. The compounds are classified under IPC categories C07D 413/14 and C07D 471/04, with pharmaceutical applications under A61K 31/426 and A61P 35/00 for antineoplastic use.

Pharmaceutical companies and researchers working in heterocyclic chemistry should note this IP development as it may affect freedom-to-operate analyses for aminothiazole-based drug discovery programs in European markets. Patent holders should monitor maintenance fee deadlines in each designated member state to preserve rights.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

NOVEL BRIDGED BICYCLOALKYL-SUBSTITUTED AMINOTHIZOLES AND THEIR METHODS OF USE

Publication EP4219486A1 Kind: A1 Apr 15, 2026

Applicants

Temple University of the Commonwealth System
of Higher Education

Inventors

CHILDERS, Wayne E., ABOU-GHARBIA, Magid A., MORTON, George C., ISSA, Jean-Pierre J., ZHANG, Hanghang

IPC Classifications

C07D 413/14 20060101AFI20230503BHEP C07D 471/04 20060101ALI20230503BHEP A61K 31/426 20060101ALI20230503BHEP A61P 35/00 20060101ALI20230503BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4219486A1

Who this affects

Applies to
Pharmaceutical companies Research institutions Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent grant Drug compound research IP protection
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!